Empowered Funds
ADPT icon

Empowered Funds’s Adaptive Biotechnologies ADPT Stock Holding History

Empowered Funds’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.6M Buy
+330,757
New +$8.12M 0.04% 473

Other funds holding ADPT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Empowered Funds's ADPT Position: Q3 2026 in Review

Empowered Funds opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2026: 330,757 shares worth $9.6M. The stake represents 0.04% of the portfolio and ranks #473 among its holdings.

244 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • Empowered Funds held 330,757 shares of Adaptive Biotechnologies worth $9.6M as of Q3 2026.
  • Adaptive Biotechnologies was a new Empowered Funds position in Q3 2026.
  • Adaptive Biotechnologies made up 0.04% of Empowered Funds's portfolio in Q3 2026, its #473 holding.
  • 244 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.